Item 8.01 Other Events
Compliance with Nasdaq Minimum Bid Price Rule
On January 28, 2020, Daré Bioscience, Inc. ("Daré") was informed that it had
regained compliance with the minimum bid price rule in Nasdaq Listing Rule
5550(a)(2). Daré issued a press release regarding the foregoing, a copy of
which is included as an exhibit to this report.
The disclosure previously reported in the Current Report on Form 8-K filed by
Daré on December 26, 2019 regarding Nasdaq Listing Rule 5550(b) and the hearing
relating thereto is incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press release issued on January 30, 2020
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses